| Benjamin M Edwards, MD | |
|
1600 Medical Center Dr, Suite 4500, Huntington, WV 25701-3656 | |
| (304) 691-1400 | |
| (304) 691-1453 |
| Full Name | Benjamin M Edwards |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 1600 Medical Center Dr, Huntington, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063471357 | NPI | - | NPPES |
| 0093907000 | Medicaid | WV | |
| 64693864 | Medicaid | KY | |
| 0380396 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 11019 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Benjamin M Edwards, MD 1600 Medical Center Dr, Suite 4500, Huntington, WV 25701-3656 Ph: (304) 691-1400 | Benjamin M Edwards, MD 1600 Medical Center Dr, Suite 4500, Huntington, WV 25701-3656 Ph: (304) 691-1400 |
News Archive
Over the past several years Americans have seen numerous food recalls related to our nation's food supply. Spinach, peanut butter and even pet food are just some of the food items that have been subject to massive recalls.
BioDuro has announced that they have entered into a strategic partnership with Roche to support discovery phase research efforts at Roche's global research sites.
Researchers have developed a new device that may result in more comfortable mammography for women. According to a study being presented next week at the annual meeting of the Radiological Society of North America, standardizing the pressure applied in mammography would reduce pain associated with breast compression without sacrificing image quality.
KemPharm, Inc. today announced that it has commenced a Phase 1 clinical trial in healthy volunteers of its novel prodrug compound, KP106, which is in development for the treatment of attention-deficit hyperactivity disorder (ADHD). KP106, a new chemical entity (NCE) composed of d-amphetamine and a ligand, is the lead investigational candidate from KemPharm's proprietary ligand activated therapy (LAT) platform, which creates improved versions of FDA-approved drugs. KemPharm began the KP106 program in 2007 and has initiated the Phase 1 clinical trial of this candidate in less than 24 months.
› Verified 2 days ago
Rafael Evencio Molina, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1630 13th Ave, Huntington, WV 25701 Phone: 304-697-2014 | |
Herbert Myers, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1630 13th Ave, Huntington, WV 25701 Phone: 304-697-2014 | |
Richard Booth Jr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1630 13th Ave, Huntington, WV 25701 Phone: 304-697-2014 | |
Dr. Jennie Lee Yoost, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1600 Medical Center Dr Ste 4500, Huntington, WV 25701 Phone: 304-691-1400 | |
William N Burns, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1600 Medical Center Dr, Suite 4500, Huntington, WV 25701 Phone: 304-691-1400 Fax: 304-691-1453 | |
Carolyn E. Clark, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1124 19th St, Huntington, WV 25701 Phone: 304-529-4117 Fax: 304-529-4110 |